Oculoplasty and Ocular Oncology Services, Dr Shroff's Charity Eye Hospital, New Delhi, India; and.
Cornea and Anterior Segment Services, Dr Shroff's Charity Eye Hospital, New Delhi, India.
Cornea. 2023 Apr 1;42(4):404-411. doi: 10.1097/ICO.0000000000003021. Epub 2022 Apr 20.
The purpose of this study was to study the outcome of single-staged entropion surgery along with lid margin mucous membrane grafting for cicatrizing ocular surface disease.
Retrospective review of medical records of patients who underwent single-staged surgical correction of cicatricial entropion along with lid margin mucous membrane grafting for lid margin keratinization.
Twenty-six eyes of 19 patients were studied. The mean age of patients was 42.5 years (standard deviation, SD-17.67), of which 7 patients were male and 12 were female. The most common disorder was Stevens-Johnson syndrome (SJS) sequelae (83.33%, n = 20), followed by mucous membrane pemphigoid (n = 4, 16.67%). The most common eyelid changes observed were cicatricial entropion in all 26 eyes (100%, n = 26), followed by trichiasis in 13 eyes (50%, n = 13). Lid margin keratinization was noted in all eyes. Postoperative improvement in corneal surface staining was noted in 70% of the patients (n = 13), no change in 20% of the patients (n = 4), and worsening of corneal surface staining in 10% of the patients (n = 2). Postoperative visual acuity improvement was noted in 50% of the eyes (n = 13), no improvement in 39% of the eyes (n = 10), and vision worsened in 12% of the eyes (n = 3). An entropion recurrence rate of 25% (n = 6) was observed over an average 10-month follow-up, whereas 75% (n = 20) reported no recurrence.
Single-staged correction of eyelid cicatricial entropion with a lid margin mucous membrane graft (MMG) has promising outcomes in ocular surface diseases. It can decrease the need for multiple surgeries and provide symptomatic relief in patients with chronic cicatricial surface changes.
本研究旨在探讨一期眼睑内翻矫正术联合睑缘黏膜移植治疗瘢痕性眼表疾病的疗效。
回顾性分析 19 例(26 只眼)因眼睑边缘角化行一期手术矫正瘢痕性内翻并联合睑缘黏膜移植的患者的病历资料。
患者的平均年龄为 42.5 岁(标准差,SD-17.67),其中男性 7 例,女性 12 例。最常见的疾病是史蒂文斯-约翰逊综合征(SJS)后遗症(83.33%,n=20),其次是黏膜炎性类天疱疮(n=4,16.67%)。所有 26 只眼均存在瘢痕性内翻(100%,n=26),其次是 13 只眼的倒睫(50%,n=13)。所有患者均存在睑缘角化。70%的患者(n=13)角膜表面染色术后改善,20%的患者(n=4)无变化,10%的患者(n=2)角膜表面染色恶化。50%的患者(n=13)术后视力提高,39%的患者(n=10)视力无改善,12%的患者(n=3)视力恶化。平均 10 个月随访时,内翻复发率为 25%(n=6),75%(n=20)报告无复发。
一期眼睑瘢痕性内翻矫正术联合睑缘黏膜移植治疗眼表疾病疗效较好,可减少多次手术的需要,并为慢性瘢痕性表面改变的患者提供症状缓解。